TY - JOUR
T1 - Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases
AU - Sharma, Swagat
AU - Hopkins, Corey R.
N1 - Funding Information:
This research was supported by a grant from the NIH (NIDDK Grant R01DK103658) to C.R.H.
Publisher Copyright:
© 2019 American Chemical Society.
PY - 2019/9/12
Y1 - 2019/9/12
N2 - Transient receptor potential canonical (TRPC) channels are highly homologous, nonselective cation channels that form many homo- and heterotetrameric channels. These channels are highly abundant in the brain and kidney and have been implicated in numerous diseases, such as depression, addiction, and chronic kidney disease, among others. Historically, there have been very few selective modulators of the TRPC family in order to fully understand their role in disease despite their physiological significance. However, that has changed recently and there has been a significant increase in interest in this family of channels which has led to the emergence of selective tool compounds, and even preclinical drug candidates, over the past few years. This review will cover these new advancements in the discovery of TRPC modulators and the emergence of newly reported structural information which will undoubtedly lead to even greater advancements.
AB - Transient receptor potential canonical (TRPC) channels are highly homologous, nonselective cation channels that form many homo- and heterotetrameric channels. These channels are highly abundant in the brain and kidney and have been implicated in numerous diseases, such as depression, addiction, and chronic kidney disease, among others. Historically, there have been very few selective modulators of the TRPC family in order to fully understand their role in disease despite their physiological significance. However, that has changed recently and there has been a significant increase in interest in this family of channels which has led to the emergence of selective tool compounds, and even preclinical drug candidates, over the past few years. This review will cover these new advancements in the discovery of TRPC modulators and the emergence of newly reported structural information which will undoubtedly lead to even greater advancements.
UR - http://www.scopus.com/inward/record.url?scp=85064970356&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064970356&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.8b01954
DO - 10.1021/acs.jmedchem.8b01954
M3 - Review article
C2 - 30943030
AN - SCOPUS:85064970356
SN - 0022-2623
VL - 62
SP - 7589
EP - 7602
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 17
ER -